These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19524700)

  • 1. Non-Edg family lysophosphatidic acid (LPA) receptors.
    Ishii S; Noguchi K; Yanagida K
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):57-65. PubMed ID: 19524700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
    Noguchi K; Ishii S; Shimizu T
    J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
    Takuwa Y; Takuwa N; Sugimoto N
    J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
    Hama K; Aoki J
    Prog Lipid Res; 2010 Oct; 49(4):335-42. PubMed ID: 20230855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands.
    Kostenis E
    J Cell Biochem; 2004 Aug; 92(5):923-36. PubMed ID: 15258916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EDG receptors and hepatic pathophysiology of LPA and S1P: EDG-ology of liver injury.
    Svetlov SI; Sautin YY; Crawford JM
    Biochim Biophys Acta; 2002 May; 1582(1-3):251-6. PubMed ID: 12069835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
    Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K
    J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.
    Lee Z; Cheng CT; Zhang H; Subler MA; Wu J; Mukherjee A; Windle JJ; Chen CK; Fang X
    Mol Biol Cell; 2008 Dec; 19(12):5435-45. PubMed ID: 18843048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
    Goetzl EJ; Kong Y; Mei B
    J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of lysophosphatidic acid (LPA) receptor and LPA-induced endometrial prostaglandin-endoperoxide synthase 2 expression in the porcine uterus.
    Seo H; Kim M; Choi Y; Lee CK; Ka H
    Endocrinology; 2008 Dec; 149(12):6166-75. PubMed ID: 18703629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells.
    Panetti TS
    Biochim Biophys Acta; 2002 May; 1582(1-3):190-6. PubMed ID: 12069828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.
    Li G; Mosier PD; Fang X; Zhang Y
    J Mol Graph Model; 2009 Aug; 28(1):70-9. PubMed ID: 19423373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
    Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
    Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current progress in non-Edg family LPA receptor research.
    Yanagida K; Kurikawa Y; Shimizu T; Ishii S
    Biochim Biophys Acta; 2013 Jan; 1831(1):33-41. PubMed ID: 22902318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Edg family LPA receptors: the cutting edge of LPA research.
    Yanagida K; Ishii S
    J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of the lysophospholipid receptor genes during mouse early development.
    Ohuchi H; Hamada A; Matsuda H; Takagi A; Tanaka M; Aoki J; Arai H; Noji S
    Dev Dyn; 2008 Nov; 237(11):3280-94. PubMed ID: 18924241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells.
    Goetzl EJ; Dolezalova H; Kong Y; Zeng L
    Cancer Res; 1999 Sep; 59(18):4732-7. PubMed ID: 10493533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.
    Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL
    J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16.
    Okamoto H; Takuwa N; Yatomi Y; Gonda K; Shigematsu H; Takuwa Y
    Biochem Biophys Res Commun; 1999 Jun; 260(1):203-8. PubMed ID: 10381367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.
    Bandoh K; Aoki J; Taira A; Tsujimoto M; Arai H; Inoue K
    FEBS Lett; 2000 Jul; 478(1-2):159-65. PubMed ID: 10922489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.